A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate the effects of treatment with Seasonique an
extended-regimen oral contraceptive that utilizes low dose ethinyl estradiol during the
typical hormone-free interval. Patients will receive 26 weeks of treatment. The overall study
duration will be approximately 9 months. Patients will be required to record menstrual pain
in a daily diary.
Phase:
Phase 3
Details
Lead Sponsor:
Duramed Research
Treatments:
Ethinyl estradiol, levonorgestrel drug combination Levonorgestrel